Clinical Trial Update: Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial completed evaluating MT-8554 for efficacy, safety, and tolerability in painful diabetic peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Peripheral Neuropathy

Drugs mentioned

• MT-8554

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Painful Diabetic Peripheral Neuropathy | Phase 2 | Status: COMPLETED